Immunovant, Inc. IMVT
33.30
(0.70)
(2.06%)
as of 25 Sep
- Market cap
- $7.1B
- P/E
- 0.0×
Follow IMVT
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
7.27 | 9.09 | 15.74 | 9.07 |
+8 more quarters Free account |
Net Debt/EBITDA |
4.98 | 5.66 | 8.70 | 3.96 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.64 | 0.83 | 0.81 | |
Capex/Depreciation |
0.00 | (0.08) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.61) | (0.52) | (0.51) | (0.59) | |
Cash per Share |
3.88 | 4.95 | 5.48 | 3.01 | |
Shareholders Equity per Share |
3.58 | 4.67 | 5.43 | 2.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.58 | 4.67 | 5.43 | 2.99 | |
Free Cash Flow |
(124.40) | (95.07) | (92.32) | (102.51) | |
Working Capital |
734.08 | 844.40 | 976.68 | 510.29 | |
Capital Expenditures |
— | (0.01) | — | — | |
Net Current Asset Value |
734.08 | 844.40 | 976.68 | 510.29 | |
| Other line items | |||||
Quick Ratio |
6.82 | 8.65 | 15.03 | 8.28 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.61) | (0.52) | (0.51) | (0.59) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
1.32 | 1.82 | 1.93 | 1.92 | |
Average Payables |
8.99 | 12.60 | 14.22 | 13.82 | |
Average Assets |
756.97 | 866.62 | 736.66 | 549.33 | |
Average Common Equity |
671.96 | 780.02 | 669.38 | 484.38 | |
Capex to Sales |
— | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates